Acurx Pharmaceuticals, Inc. - ACXP

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2025 · Q2 2025
Value (USD)
Total reported value ($000)
$36K
QoQ value delta ($000)
-$1.39M (-97.48%)
Implied price effect (QoQ)
+25.77%
Shares
Total shares
55,571
QoQ shares delta
-2,713,022 (-97.99%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (ACXP)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2025)

Top 25 only Full list
Early Q4 2025 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Virtu Financial LLC 12 16,225 0.0%
GEODE CAPITAL MANAGEMENT, LLC 10 14,350 0.0%
TWO SIGMA SECURITIES, LLC 8 10,982 0.0%
Tower Research Capital LLC (TRC) 3 4,517 0.0%
OSAIC HOLDINGS, INC. 2 7,584 0.0%
CITIGROUP INC 1 1,645 0.0%
BANK OF AMERICA CORP /DE/ 0 41 0.0%
MORGAN STANLEY 0 1 0.0%
GROUP ONE TRADING LLC 0 2 0.0%
UBS Group AG 0 134 0.0%
IFP Advisors, Inc 0 1 0.0%
Darwin Wealth Management, LLC 0 1 0.0%
SBI Securities Co., Ltd. 0 87 0.0%
TD Waterhouse Canada Inc. 0 1 0.0%